Diagnos Inc V.ADK

Alternate Symbol(s): DGNOF

Healthcare Medical Devices

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

TSXV:ADK - Post by User

Diagnos Inc

Bullboard Posts

Comment by Lagrenouilleon Jan 11, 2018 8:21am

122 Views

Post# 27331923

RE:How much revenue for IDK .

No numbers specified for now but you can guess this can be very high for ADK.
The most important aspect is the recognition of ADK technology by giant pharmaceutical like Novo Nordisk and others will follow.
Pharmaceutical companies have money and they want to treat and sell there cures for the diagnosed retinal problems, cardiac will follow.
ADK market cap is a joke in regards to the potential revenue growth path.
MHO

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price